The list of target genes includes genes with already known DNA methylation abnormalities, such as hypermethylation of ABL1, and genes that are overexpressed in BC-CML, such as PRAME, WT1 and GAS2 [89,90,91]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.